Enterprise Value to EBITDA Multiple ratio Analysis of Adc Therapeutics SA - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Sep-23
Very Poor EV to EBITDA
-0.895
Period Ending - Sep-22
Very Poor EV to EBITDA
-0.074
Growth
-1107.33 %
Trailing Twelve Months EV to EBITDA
Period Ending - Sep-23
Very Poor EV to EBITDA
-1.13
EV to EBITDA Analysis of Adc Therapeutics SA
| EV to EBITDA Ratio of ADCT drastically fell by -1107.33 % this year. |
| EV to EBITDA Ratio with value of 0.475 was highest in Year Sep-21 in last Five Years. |
| EV to EBITDA Ratio with value of -0.895 was lowest in Year Sep-23 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -0.895 is lower than Average EV to EBITDA of -0.136 in last five years. |
Other EV to EBITDA Related Info of ADCT that may interest you.
Adc Therapeutics SA Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ADCT | 3.43 | 3.44 | 0.291 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Adc Therapeutics SA
| Period | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -0.895 | -0.074 | 0.475 | 0.428 | -0.615 | -0.516 | 0.680 |
| Change | -1107.33 % | -115.61 % | 10.97 % | 169.54 % | -19.19 % | -175.88 % |
FY Chart of Enterprise Value to EBITDA Multiple of Adc Therapeutics SA
Note : All Data Generated at the End of Trading Hours (EOD Data)